Is the efficacy of successful infliximab induction therapy maintained for one year lasting without retreatment in different behavior types of Crohn's disease?
暂无分享，去创建一个
F. Nagy | T. Wittmann | T. Molnár | Z. Tulassay | Z. Szepes | P. Miheller | T. Nyári | L. Herszényi | K. Farkas | G. Müzes
[1] T. Piche. Impact de la chirurgie gynécologique sur le développement du syndrome de l’intestin irritable et des douleurs abdominales , 2008 .
[2] E. Cabré,et al. Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? , 2005, Alimentary pharmacology & therapeutics.
[3] S. Ghosh,et al. Prediction of response to infliximab in Crohn's disease. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[4] P. Rutgeerts,et al. Infliximab maintenance therapy for fistulizing Crohn's disease. , 2004, The New England journal of medicine.
[5] C. Fiocchi. Closing fistulas in Crohn's disease--should the accent be on maintenance or safety? , 2004, The New England journal of medicine.
[6] M. Cottone,et al. Maintenance infliximab for Crohn's disease , 2002, The Lancet.
[7] J. Achkar,et al. Predictors of response to infliximab in patients with Crohn's disease. , 2002, Gastroenterology.
[8] W. Tremaine,et al. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease]. , 2006, Revista de gastroenterologia de Mexico.
[9] J. Lennard-jones,et al. Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.